Impact of intensive care unit-acquired infection on hospital mortality in Japan: A multicenter cohort study

  • Machi Suka
  • Katsumi Yoshida
  • Jun Takezawa
Original Article



To elucidate factors associated with hospital mortality in intensive care unit (ICU) patients and to evaluate the impact of ICU-acquired infection on hospital mortality in the context of the drug resistance of pathogens.


By using the Japanese Nosocomial Infection Surveillance (JANIS) database, 7,374 patients who were admitted to the 34 participating ICUs between July 2000 and May 2002, were aged 16 years or older, and who stayed in the ICU for 48 to 1,000 hours, did not transfer to another ICU, and did not become infected within 2 days after ICU admission, were followed up until hospital discharge or to Day 180 after ICU discharge. Adjusted hazard ratios (HRs) with the 95% confidence intervals (CIs) for hospital mortality were calculated using Cox’s proportional hazard model.


After adjusting for sex, age, and severity-of-illness (APACHE II score), a significantly higher HR for hospital mortality was found in ventilator use, central venous catheter use, and ICU-acquired drug-resistant infection, with a significantly lower HR in elective or urgent operations and urinary catheter use. The impact of ICU-acquired infection on hospital mortality was different between drug-susceptible pathogens (HR 1.11,95% CI:0.94–1.31) and drug-resistant pathogens (HR 1.42,95% CI: 1.15–1.77).


The use of a ventilator or a central venous catheter, and ICU-acquired drug-resistant infection were associated with a high risk of hospital mortality in ICU patients. The potential impact on hospital mortality emphasizes the importance of preventive measures against ICU-acquired infections, especially those caused by drug-resistant pathogens.

Key words

multicenter cohort study hospital mortality ICU nosocomial infection drug resistance 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. (1).
    Fridkin SK, Welbel SF, Weinstein RA. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am 1997;11:479–496.PubMedCrossRefGoogle Scholar
  2. (2).
    Albrich WC, Angstwurm M, Bader L, Gartner R. Drug resistance in intensive care units. Infection 1999;27(suppl):S19-S23.PubMedCrossRefGoogle Scholar
  3. (3).
    Vincent J, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin M, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995;274:639–644.PubMedCrossRefGoogle Scholar
  4. (4).
    Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lapage E, Le Gall JR. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002;28:108–121.PubMedCrossRefGoogle Scholar
  5. (5).
    Jencks SF, Daley J, Draper D, Thomas N, Lenhart G, Walker J. Interpreting hospital mortality data: the role of clinical risk adjustment. JAMA 1988;260:3611–3616.PubMedCrossRefGoogle Scholar
  6. (6).
    Green J, Wintfeld N, Sharkey P, Passman LJ. The importance of severity of illness in assessing hospital mortality. JAMA 1990;263:241–246.PubMedCrossRefGoogle Scholar
  7. (7).
    Niederman MS. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med 2001; 29(suppl):N114-N120.PubMedCrossRefGoogle Scholar
  8. (8).
    Sakakibara Y, Takezawa J. Report of the Japan Nosocomial Infection Surveillance, ICU division. Infection Control 2002; 11:530–536 (in Japanese).Google Scholar
  9. (9).
    Furuya N, Yamaguchi K. Report of the Japan Nosocomial Infection Surveillance, Laboratory division. Infection Control 2002;11:538–543 (in Japanese).Google Scholar
  10. (10).
    Manabe K, Miyazaki H, Kawano F, Arakawa Y, Okabe N, Shindo N, Uno H. Report of the Japan Nosocomial infection Surveillance, Hospitalwide division. Infection Control 2002;11:546–550 (in Japanese).Google Scholar
  11. (11).
    The 2003 Report of Health and Labour Sciences Research Grant (Research on Emergent or Revival Infections), “Research on network of drug-resistant infection surveillance”, 2003 (in Japanese).Google Scholar
  12. (12).
    Takezawa J. Surveillance system for nosocomial infections due to drug-resistant organisms in Japan and other countries. Nippon Rinsho 2001;59:126–134 (in Japanese).Google Scholar
  13. (13).
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–829.PubMedCrossRefGoogle Scholar
  14. (14).
    The 2000 Report of Health and Labour Sciences Research Grant (Research on Emergent or Revival Infections), “Research on development of drug-resistant infection surveillance system”, 2000 (in Japanese).Google Scholar
  15. (15).
    Garner JS, Javis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections 1988. Am J Infect Control 1988;16:128–140.PubMedCrossRefGoogle Scholar
  16. (16).
    Cox DR. Regression models and life-tables. J Royal Stat Soc Series B 1972;34:187–220.Google Scholar
  17. (17).
    Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462–474.PubMedCrossRefGoogle Scholar
  18. (18).
    Zaidi M, Sifuentes-Osornio J, Rolon AL, Vazquez G, Rosado R, Sanchez M, Calva JJ, de Leon-Rosales SP. Inadequate therapy and antibiotic resistance: risk factors for mortality in the intensive care unit. Arch Med Res 2002;33:290–294.PubMedCrossRefGoogle Scholar
  19. (19).
    Craven DE, Kunches LM, Lichtenberg DA, Kollisch NR, Barry MA, Heeren TC, McCabe WR. Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988;148:1161–1168.PubMedCrossRefGoogle Scholar
  20. (20).
    Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001;134:298–314.PubMedGoogle Scholar
  21. (21).
    Leon-Rosales SP, Molinar-Romas F, Dominguez-Cherit G, Rangel-Frausto S, Vazquez-Ramos VG. Prevalence of infections in intensive care units in Mexico: multicenter study. Crit Care Med 2000;28:1316–1321.CrossRefGoogle Scholar
  22. (22).
    Pronovost PJ, Jenckes MW, Dorman T, Garrestt E, Breslow MJ, Rosenfeld BA, Lipsett PA, Bass E. Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA 1999;281:1310–1317.PubMedCrossRefGoogle Scholar
  23. (23).
    Pronovost PJ, Angus DC, Robinson KA, Dremsizov TT, Young TL. Physician staffing patterns and clinical outcomes in critically ill patients. JAMA 2002;288:2151–2162.PubMedCrossRefGoogle Scholar
  24. (24).
    Vincent JL. Microbial resistance: lessons from the EPIC study. Intensive Care med 2000;26:S3-S8.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society of Hygiene 2004

Authors and Affiliations

  1. 1.Department of Preventive MedicineSt. Marianna University School of MedicineKawasaki, KanagawaJapan
  2. 2.Department of Emergency and Intensive Care MedicineNagoya University Graduate School of MedicineNagoyaJapan

Personalised recommendations